糖基化先天性疾病的治疗未来
I J J Muffels1, T Kozicz1,2, E O Perlstein3
1Department of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Journal of inherited metabolic disease
|March 10, 2025
概括
对于先天性糖基化乱 (CDG) 的新型治疗方法正在推进,但需要进行大量的临床试验. 本文探讨了使用疾病模型,试验准备和可扩展的个性化治疗方法来克服治疗CDG的挑战.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 先天性糖基化乱 (CDG) 是一组罕见的遗传疾病.
- 近年来,CDG的治疗策略取得了重大进展.
- 目前的治疗方法正在从研究转向临床应用.
研究的目的:
- 为CDG提供了推进治疗策略的概述.
- 为应对大量遗传缺陷和所需的临床试验所带来的挑战.
- 概述CDG治疗发展的未来方向.
主要方法:
- 专注于三个关键领域:疾病模型,临床试验准备和可扩展的个性化治疗.
- 审查当前文献和CDG研究的新兴趋势.
- 分析罕见遗传疾病临床开发中的挑战.
主要成果:
- 针对CDG的原因和表现的新疗法正在出现.
- 对于所有已知的190种CDG遗传缺陷进行临床试验存在重大挑战.
- 疾病模型,改进的临床试验基础设施和可扩展的个性化医疗对未来的进步至关重要.
结论:
- CDG治疗的未来取决于临床开发的创新方法.
- 整合先进的疾病模型和高效的试验设计是必不可少的.
- 可扩展的个性化疗法对整个CDG患者群体具有前景.
相关概念视频
Inborn Errors of Metabolism
121
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
121
Gene Therapy
25.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.1K
Glucose Transporters
22.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.3K
Proteoglycans
3.8K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.8K
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Oligosaccharide Assembly
2.7K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.7K


